187 related articles for article (PubMed ID: 997590)
21. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
[TBL] [Abstract][Full Text] [Related]
22. Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans.
Scatina JA; Wells DS; Kimmel HB; Kemper CJ; Sisenwine SF
Drug Metab Dispos; 1990; 18(5):746-52. PubMed ID: 1981731
[TBL] [Abstract][Full Text] [Related]
23. [Metabolism of methiothepin in the rat, dog and man].
Eschenhof E; Meister W; Oesterhelt G; Vetter W
Arzneimittelforschung; 1976 Feb; 26(2):262-71. PubMed ID: 947211
[TBL] [Abstract][Full Text] [Related]
24. The pharmacokinetics of nitrendipine. I. Absorption, plasma concentrations, and excretion after single administration of [14C]nitrendipine to rats and dogs.
Krause HP; Ahr HJ; Beermann D; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Nov; 38(11):1593-9. PubMed ID: 3214442
[TBL] [Abstract][Full Text] [Related]
25. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
26. Disposition and metabolism of a novel diurea inhibitor of acyl CoA: cholesterol acyltransferase (YM17E) in the rat and dog.
Uchida T; Nakamura E; Usui T; Imasaki H; Kawakami R; Watanabe T; Higuchi S
Xenobiotica; 1994 Dec; 24(12):1223-36. PubMed ID: 7771109
[TBL] [Abstract][Full Text] [Related]
27. Biotransformation of sultopride in man and several animal species.
Kobari T; Namekawa H; Kato Y; Yamada S
Xenobiotica; 1985 Jun; 15(6):469-76. PubMed ID: 4036171
[TBL] [Abstract][Full Text] [Related]
28. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W
Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
[TBL] [Abstract][Full Text] [Related]
29. Plasma levels, biotransformation and excretion of oxatomide (R 35 443) in rats, dogs and man.
Meuldermans W; Hendrickx J; Knaeps F; Lauwers W; Heykants J; Grindel JM
Xenobiotica; 1984 Jun; 14(6):445-62. PubMed ID: 6475104
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
[TBL] [Abstract][Full Text] [Related]
31. Absorption, metabolism, and excretion of 14C-tosifen in the dog and rat.
Lin C; Foester R; Lim J; Hsu T; Morton JB; Symchowicz S
Drug Metab Dispos; 1978; 6(1):50-8. PubMed ID: 23274
[TBL] [Abstract][Full Text] [Related]
32. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
33. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.
Vickers S; Duncan CA; Slaughter DE; Arison BH; Greber T; Olah TV; Vyas KP
Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219
[TBL] [Abstract][Full Text] [Related]
34. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
Prakash C; Kamel A; Gummerus J; Wilner K
Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
[TBL] [Abstract][Full Text] [Related]
35. Metabolsim of vasodilator 4-(3,4,5-trimethoxycinnamoyl)-1-(1-pyrrolidinyl)carbonylmethylpiperazine (cinepazide): isolated and identification of metabolites in the rat and man.
Nomura H; Tsumura M; Takasugi N; Sano M
J Pharmacobiodyn; 1980 Jun; 3(6):281-9. PubMed ID: 7420263
[TBL] [Abstract][Full Text] [Related]
36. Biotransformation of bromperidol in rat, dog, and man.
Wong FA; Bateman CP; Shaw CJ; Patrick JE
Drug Metab Dispos; 1983; 11(4):301-7. PubMed ID: 6137334
[TBL] [Abstract][Full Text] [Related]
37. Disposition and metabolism of 3-(3-chlorophenoxy)-N-methylpyrrolidine [14C]-carboxamide in the rat, dog, and man.
Turnbull LB; Teng L; Newman J; Bruce RB; Maynard WR
Drug Metab Dispos; 1976; 4(4):379-86. PubMed ID: 8294
[TBL] [Abstract][Full Text] [Related]
38. Metabolism of the anti-psoriatic agent 5-methoxypsoralen in humans: comparison with rat and dog.
John BA; Chasseaud LF; Wood SG; Forlot P
Xenobiotica; 1992 Nov; 22(11):1339-51. PubMed ID: 1492426
[TBL] [Abstract][Full Text] [Related]
39. The physiological disposition of the anti-tussive agent, 1,2,3,4a,9b-hexahydro-8,9b-dimethyl-4-[3-(4-methylpiperazin-1-yl)propionamido]dibenzofuran-3-one dihydrochloride Azipranone, in man, rat, dog and baboon.
Daniel JW; James GW; Rowlands DA; Taylor JB
Xenobiotica; 1978 May; 8(5):321-9. PubMed ID: 96617
[TBL] [Abstract][Full Text] [Related]
40. Biotransformation of the novel inotropic agent toborinone (OPC-18790) in rats and dogs. Evidence for the formation of novel glutathione and two cysteine conjugates.
Kitani M; Miyamoto G; Nagasawa M; Yamada T; Matsubara J; Uchida M; Odomi M
Drug Metab Dispos; 1997 Jun; 25(6):663-74. PubMed ID: 9193867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
